Switch theme
Sign up to access all valuation multiples
Cannabist Company Holdings Inc through its subsidiaries, operates as a cultivator, manufacturer, and provider of medical and adult-use cannabis products. Some of its products are vaporization oil, sublingual tinctures, lotions, hard-pressed tablets, and suppositories, among others which are marketed through brands like Classix, dreamt, Triple Seven, Amber, Press, Heady, and Seed and Strain. The company operates its businesses in California, Colorado, Delaware, Illinois, Maryland, Massachusetts, New Jersey, New York, Ohio, Pennsylvania, Virginia, and West Virginia.
2018
1.6K+
LTM Revenue $619M
LTM EBITDA $70.8M
$450M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
The Cannabist Company has a last 12-month revenue of $619M and a last 12-month EBITDA of $70.8M.
In the most recent fiscal year, The Cannabist Company achieved revenue of $321M and an EBITDA of $20.0M.
The Cannabist Company expects next 12-month revenue of XXX and NTM EBITDA of XXX
See The Cannabist Company valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $358M | $321M | XXX | XXX | XXX |
| Gross Profit | $141M | $126M | XXX | XXX | XXX |
| Gross Margin | 39% | 39% | XXX | XXX | XXX |
| EBITDA | -$35.9M | $20.0M | XXX | XXX | XXX |
| EBITDA Margin | -10% | 6% | XXX | XXX | XXX |
| Net Profit | -$291M | -$123M | XXX | XXX | XXX |
| Net Margin | -81% | -38% | XXX | XXX | XXX |
| Net Debt | $196M | $187M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, The Cannabist Company's stock price is CAD 0 (or $0).
The Cannabist Company has current market cap of CAD 26.0M (or $18.2M), and EV of CAD 643M (or $450M).
See The Cannabist Company trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $450M | $18.2M | XXX | XXX | XXX | XXX | $-0.34 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, The Cannabist Company has market cap of $18.2M and EV of $450M.
The Cannabist Company's trades at 1.0x LTM EV/Revenue multiple, and 9.1x LTM EBITDA.
Analysts estimate The Cannabist Company's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for The Cannabist Company and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $450M | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | XXX | XXX |
| EV/EBITDA | 22.5x | XXX | XXX | XXX |
| P/E | -0.2x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | -22.0x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpThe Cannabist Company's NTM/LTM revenue growth is -15%
The Cannabist Company's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, The Cannabist Company's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate The Cannabist Company's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for The Cannabist Company and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -10% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -156% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | -9% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 1% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 35% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 41% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Ascend Wellness Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Ayr Wellness | XXX | XXX | XXX | XXX | XXX | XXX |
| Cresco Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Grown Rogue | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
The Cannabist Company acquired XXX companies to date.
Last acquisition by The Cannabist Company was XXXXXXXX, XXXXX XXXXX XXXXXX . The Cannabist Company acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was The Cannabist Company founded? | The Cannabist Company was founded in 2018. |
| Where is The Cannabist Company headquartered? | The Cannabist Company is headquartered in Canada. |
| How many employees does The Cannabist Company have? | As of today, The Cannabist Company has 1.6K+ employees. |
| Is The Cannabist Company publicy listed? | Yes, The Cannabist Company is a public company listed on NEOE. |
| What is the stock symbol of The Cannabist Company? | The Cannabist Company trades under CBST ticker. |
| When did The Cannabist Company go public? | The Cannabist Company went public in 2019. |
| Who are competitors of The Cannabist Company? | Similar companies to The Cannabist Company include e.g. Live Verdure, Ascend Wellness Holdings, Ayr Wellness, Cresco Labs. |
| What is the current market cap of The Cannabist Company? | The Cannabist Company's current market cap is $18.2M |
| What is the current revenue of The Cannabist Company? | The Cannabist Company's last 12-month revenue is $619M. |
| What is the current EBITDA of The Cannabist Company? | The Cannabist Company's last 12-month EBITDA is $70.8M. |
| What is the current EV/Revenue multiple of The Cannabist Company? | Current revenue multiple of The Cannabist Company is 1.0x. |
| What is the current EV/EBITDA multiple of The Cannabist Company? | Current EBITDA multiple of The Cannabist Company is 9.1x. |
| What is the current revenue growth of The Cannabist Company? | The Cannabist Company revenue growth between 2023 and 2024 was -10%. |
| Is The Cannabist Company profitable? | Yes, The Cannabist Company is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
